NAPLES, Fla., Sept. 16, 2019 /PRNewswire/ -- A simple, quick cure for Alzheimer's disease (AD) will be a "medical miracle", but will also slash $67 billion of revenue from nursing home operators and assisted living companies, plus cause the loss of 654,000 nursing home jobs, predicts Leslie Norins, M.D., P

­­­­ARTARMON, Australia, Sept. 16, 2019 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") today announced the award of CE Mark and the European commercial launch of the Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System for the treatment of chronic pain. The world's first commercial implants were completed in The N

CENTER VALLEY, Pa., Sept. 15, 2019 /PRNewswire/ -- Central Learning, a web-based coding assessment and education application, released the results of the 4th annual nationwide ICD-10

PALO ALTO, Calif., Sept. 15, 2019 /PRNewswire/ -- Strengthening its leadership in delivering innovative new solutions to transform cancer care globally, Varian (NYSE: VAR) today announced Ethos™ therapy, an Adaptive Intelligence™ solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution designed to inc

TEMPE, Ariz., Sept. 15, 2019 /PRNewswire/ -- Nocira, LLC announces its fourth and fifth US Patents, US 10,251,790 and 10,278,868, issued by the U.S. Patent and Trademark Office related to its novel approach for treating headaches via ear pressure modulation.

FOOTHILL RANCH, Calif., Sept. 15, 2019 /PRNewswire/ -- TAE Life Sciences, a company pioneering a new cancer treatment platform that addresses limitations in current cancer the

STOCKHOLM, Sept. 15, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today updated interim efficacy and safety data from the ongoing pivotal Phase 2 study, HORIZON, at the 17th International Myeloma Workshop (IMW) meeting in Boston, Massachusetts, USA. The data focused on patients with extramedullary

BOSTON, Sept. 15, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the randomized Phase 2 GRIFFIN (MMY2004) stu

PALO ALTO, Calif., Sept. 15, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical-stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced emerging durability data in patients with wet age-related macular degeneration (AMD) treated in its Phase 1b

TENAFLY,  N.J., Sept. 14, 2019 /PRNewswire/ -- Sensible Medical Innovations today announced the launch of the ReDSTM PRO system. The debut of the new system was at the Heart Failure society of America conference in Philadelphia, PA. ReDSTM PRO is optimized for the Point-of-Care, designed for use in h